{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:20:34Z","timestamp":1773789634448,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdcjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jdiacomp.2017.02.012","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T07:16:30Z","timestamp":1488438990000},"page":"859-863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Updated risk factors should be used to predict development of diabetes"],"prefix":"10.1016","volume":"31","author":[{"given":"Mary Angelyn","family":"Bethel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1087-740X","authenticated-orcid":false,"given":"Kristen A.","family":"Hyland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio R.","family":"Chacra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Deedwania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory R.","family":"Fulcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1256-874X","authenticated-orcid":false,"given":"Rury R.","family":"Holman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trond","family":"Jenssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi S.","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-3975","authenticated-orcid":false,"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6927-3734","authenticated-orcid":false,"given":"Eleni","family":"Boutati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4453-9441","authenticated-orcid":false,"given":"Jie-Lena","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0005","doi-asserted-by":"crossref","first-page":"e637S","DOI":"10.1378\/chest.11-2306","article-title":"Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Vandvik","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0010","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00125-010-1990-7","article-title":"The evaluation of screening and early detection strategies for type 2 diabetes and impaired glucose tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes","volume":"54","author":"Alssema","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0015","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.26.3.725","article-title":"The diabetes risk score: a practical tool to predict type 2 diabetes risk","volume":"26","author":"Lindstrom","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0020","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1056\/NEJMoa0804742","article-title":"Genotype score in addition to common risk factors for prediction of type 2 diabetes","volume":"359","author":"Meigs","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00125-008-1232-4","article-title":"A prediction model for type 2 diabetes risk among Chinese people","volume":"52","author":"Chien","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7326\/0003-4819-136-8-200204160-00006","article-title":"Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?","volume":"136","author":"Stern","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0035","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2337\/diacare.28.8.2013","article-title":"Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study","volume":"28","author":"Schmidt","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0040","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00125-013-2854-8","article-title":"Change in HbA1c over 3 years does not improve the prediction of cardiovascular disease over and above HbA1c measured at a single time point","volume":"56","author":"Chamnan","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.amjcard.2013.03.019","article-title":"A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk","volume":"112","author":"Bethel","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ahj.2008.05.017","article-title":"Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide and valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial","volume":"156","author":"Califf","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0055","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMoa1001122","article-title":"Effect of nateglinide on the incidence of diabetes and cardiovascular events","volume":"362","author":"Holman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0060","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1001121","article-title":"Effect of valsartan on the incidence of diabetes and cardiovascular events","volume":"362","author":"NAVIGATOR Study Group","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-152-3-201002020-00019","article-title":"Reclassification calculations for persons with incomplete follow-up","volume":"152","author":"Steyerberg","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0080","doi-asserted-by":"crossref","first-page":"b880","DOI":"10.1136\/bmj.b880","article-title":"Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore","volume":"338","author":"Hippisley-Cox","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0085","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1373\/clinchem.2010.146779","article-title":"Lipoprotein(a) and risk of type 2 diabetes","volume":"56","author":"Mora","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0090","first-page":"11","article-title":"Low \"quotient\" Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk","volume":"123","author":"Onat","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archinternmed.2011.625","article-title":"Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative","volume":"172","author":"Culver","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0100","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1365-2125.2012.04403.x","article-title":"Statins and risk of treated incident diabetes in a primary care population","volume":"75","author":"Zaharan","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2261-14-85","article-title":"Statins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice pesearch [sic] datalink","volume":"14","author":"Macedo","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0110","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","article-title":"Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort","volume":"58","author":"Cederberg","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0120","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0125","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.amjcard.2012.12.037","article-title":"Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus","volume":"111","author":"Navarese","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0135","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2017.02.012_bb0140","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes\u20142013","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872716304172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872716304172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T18:28:00Z","timestamp":1535999280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872716304172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1056872716304172"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.02.012","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updated risk factors should be used to predict development of diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}